A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis

<h4>Background</h4> <p>In the absence of a validated animal model and/or an immune correlate which predict vaccine-mediated protection, large-scale clinical trials are currently the only option to prove efficacy of new tuberculosis candidate vaccines. Tools to facilitate testing of...

Full description

Bibliographic Details
Main Authors:	McShane, H, Tanner, R, Zelmer, A, Stylianou, E, Damelang, T, Morris, S, Izzo, A, Williams, A, Sharpe, S, Pepponi, I, Walker, B, Hokey, D, Brennan, M, Fletcher, H
Format:	Journal article
Published:	BioMed Central 2016

Similar Items

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
by: Painter, H, et al.
Published: (2024)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
by: Marsay, L, et al.
Published: (2013)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
by: Marsay, L, et al.
Published: (2013)

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
by: Brennan, M, et al.
Published: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
by: Tanner, R, et al.
Published: (2021)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
by: Painter, H, et al.
Published: (2020)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
by: O'Shea, M, et al.
Published: (2018)

Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells
by: Prabowo, SA, et al.
Published: (2019)

Vaccination against tuberculosis: how can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Vaccination against tuberculosis: How can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
by: Poyntz, H, et al.
Published: (2014)

New tuberculosis vaccines can diminish as well as enhance BCG induced protection: Results from a murine model
by: Sander, C, et al.
Published: (2006)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
by: Mcshane, H, et al.
Published: (2017)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
by: Poyntz, H, et al.
Published: (2014)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
by: Satti, I, et al.
Published: (2022)

Development of a primate model for tuberculosis vaccine research: IFN-gamma responses induced by BCG vaccination and M-tuberculosis infection in macaques
by: Dowall, S, et al.
Published: (2007)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
by: Tanner, R, et al.
Published: (2011)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
by: Fletcher, H, et al.
Published: (2013)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
by: Harris, SA, et al.
Published: (2014)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
by: Pepponi, I, et al.
Published: (2017)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
by: Mcshane, H, et al.
Published: (2005)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
by: Harris, S, et al.
Published: (2017)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
by: O'Shea, M, et al.
Published: (2018)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
by: Iman Satti, et al.
Published: (2022-11-01)

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis
by: Bettencourt, P, et al.
Published: (2019)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
by: Matsumiya, M, et al.
Published: (2014)

High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis
by: Zelmer, A, et al.
Published: (2018)

Vaccines for tuberculosis
by: McShane, H
Published: (2013)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
by: Villarreal-Ramos, B, et al.
Published: (2017)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
by: Painter, H, et al.
Published: (2024)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
by: Tanner, R, et al.
Published: (2016)

Human and Bovine Tuberculosis
by: McShane, H
Published: (2016)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
by: Griffiths, K, et al.
Published: (2013)

Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models.
by: O'Sullivan, D, et al.
Published: (2007)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
by: Williams, A, et al.
Published: (2005)

The humoral immune response to BCG vaccination
by: Tanner, R, et al.
Published: (2019)

Tuberculosis vaccines: Progress and challenges
by: Checkley, A, et al.
Published: (2011)

Vaccine strategies against tuberculosis
by: H McShane
Published: (2009-03-01)

Understanding BCG is the key to improving it.
by: McShane, H
Published: (2013)

Revaccination with BCG: does it work?
by: McShane, H
Published: (2024)